Clinical Trial Update: A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update for molidustat in correcting renal anemia in dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Renal Insufficiency Chronic

Drugs mentioned

• Molidustat (molidustat)

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED